Join us for an engaging seminar with Dr. Anh Wartel, MD, Head of Europe Regional Office at the International Vaccine Institute, to explore practical strategies for improving HPV vaccine adoption through public-private partnerships. Learn how collaboration can expand access to critical healthcare and improve public health outcomes.

• How can public-private partnerships improve HPV vaccine uptake globally?
• What are the critical challenges and opportunities in promoting HPV vaccination?
• Why is enhancing HPV vaccine coverage essential for addressing cervical cancer and public health?
• How can life science organizations contribute to scalable and sustainable vaccination programs?

This seminar runs alongside the World Economic Forum’s Access to Medicine Hackathon at the House of Equity in Davos, reflecting a shared commitment to advancing healthcare access worldwide.

Don’t miss this opportunity to explore practical approaches and impactful solutions to advancing global health initiatives.

All the best,
The Park Team

About the International Vaccine Institute (IVI)

The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.

IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO), and developed a new-generation typhoid conjugate vaccine that also achieved WHO prequalification in early 2024.

IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, a Country Office in Austria, an Africa Regional Office in Rwanda and a Country Office in Kenya. 42 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, Austria, and Thailand provide state funding.

For more information, please visit https://www.ivi.int.